Company news

Sisram Medical Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026

November 3, 2026

Next Day Disclosure Return

November 2, 2026

Next Day Disclosure Return

October 30, 2026

Documents on Display

October 28, 2026

Form of proxy for the extraordinary general meeting on Thursday, December 3, 2026

October 28, 2026

Notice of extraordinary general meeting

October 28, 2026

(1) Renewal of continuing connected transactions relating to the new sublicense agreement and the new promotional services agreements and (2) notice of extraordinary general meeting

October 28, 2026

Next Day Disclosure Return

October 28, 2026

Next Day Disclosure Return

October 23, 2026

Next Day Disclosure Return

October 21, 2026

Delay in despatch of circular

October 21, 2026

Next Day Disclosure Return

October 20, 2026

Next Day Disclosure Return

October 16, 2026

Next Day Disclosure Return

October 15, 2026

Next Day Disclosure Return

October 13, 2026

Next Day Disclosure Return

October 12, 2026

Next Day Disclosure Return

October 9, 2026

Sisram Medical Announces Share Repurchase Plan for Up to 1% of Issued Shares

October 8, 2026

Voluntary announcement share repurchase plan

October 8, 2026

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026

October 5, 2026

Renewal of continuing connected transactions relating to the new sublicense agreement and the new promotional services agreements

September 28, 2026

Continuing connected transactions extension of the new sublicense agreement and the new promotional services agreements

September 28, 2026

Interim report 2026

September 28, 2026

Sisram Medical Delivers Solid 2026 Interim Results

August 19, 2026

Sisram Medical to Announce 2026 Interim Results on Wednesday, August 19, 2026

August 5, 2026

Sisram Medical Launches Titanium Prime Treatment Concept in Hong Kong SAR

August 4, 2026

Sisram Medical Powers Up China EBD Growth Engine with Flagship "黑金牛奶光" Launch

August 4, 2026

Sisram Medical's China Manufacturing Facility Commences Operations as First Locally Produced Alma Rejuve Rolls Off the Line

June 28, 2026

Sisram Medical Bolsters EBD and Injectables in Thailand to Unlock APAC Growth

June 22, 2026

Sisram Medical Investor Day Key Takeaways

May 27, 2026

Sisram Medical Reports Solid Growth in 2025

March 23, 2026

Sisram Medical to Announce 2025 Annual Results on Monday, March 23, 2026

March 12, 2026

Alma, a Sisram Medical Company, Advances the Future of Intelligent Aesthetics at IMCAS World Congress 2026

February 6, 2026

Sisram Medical Partners with Sinmait Medical Technology to Build Next-Generation Manufacturing and Innovation Hub in China

January 21, 2026

Sisram Medical Reports Completion of NIFDC Testing for DAXXIFY in China

January 5, 2026

Alma Announces Leadership Transition; Lior Dayan Appointed Chairman of Sisram Medical Following Eight Years of Successful Leadership as CEO

December 9, 2025

Sisram Medical Launches Universkin by Alma in Hong Kong, Pioneering a New Era of AI-assisted Personalized Skincare

November 21, 2025

Sisram Medical Delivers Strong Third-Quarter 2025 Performance with Robust Momentum Across Key Markets and Core Businesses

October 28, 2025

Alma, a Sisram Medical Company, Announces Strategic Collaboration with Celebrity Skin Expert Nurse Jamie to Expand Global Consumer Presence

September 4, 2025

Vaulta and Solana Support Fosun's Launch of First-Ever On-Chain Hong Kong-Listed Shares, Representing $328 Million in Market Value

September 2, 2025

Sisram Medical Reports First-Half 2025 Results: Injectables Surge as AI-Powered EBD Strengthens Segment Positioning

August 20, 2025

Sisram Medical will Report H1 2025 Financial Results on August 20 and Hold a Conference Call on August 21

August 14, 2025

Sisram Medical Announces 2024 Annual Results

March 19, 2025

Sisram Medical to Report FY 2024 Financial Results on March 19 and Hold a Conference Call on March 20

March 13, 2025

Sirsram Medical announces NMPA approval for DAXXIFY®

September 9, 2024

Sisram Medical Announces First-Half 2024 Financial Results

August 21, 2024

Sisram Medical to Report H1 2024 Financial Results on August 21 and Hold a Conference Call on August 22

August 14, 2024

Sisram Medical Announces 2023 Annual Results

March 20, 2024

Alma, a Sisram Medical company, is establishing a direct operation in China after completing the acquisition of PhotonMed

July 3, 2023

Sisram Medical Expands Footprint in Mainland China, Acquires Giant Medical Aesthetic Distributor - PhotonMed

March 30, 2023

Older news releases →

Calls

Decks